Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
- PMID: 10433618
- DOI: 10.1093/jnci/91.15.1295
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers
Abstract
Background: Microsatellite instability (MSI) and allelic imbalance involving chromosome arms 5q, 8p, 17p, and 18q are genetic alterations commonly found in colorectal cancer. We investigated whether the presence or absence of these genetic alterations would allow stratification of patients with Astler-Coller stage B2 or C colorectal cancer into favorable and unfavorable prognostic groups.
Methods: Tumors from 508 patients were evaluated for MSI and allelic imbalance by use of 11 microsatellite markers located on chromosome arms 5q, 8p, 15q, 17p, and 18q. Genetic alterations involving each of these markers were examined for associations with survival and disease recurrence. All P values are two-sided.
Results: In univariate analyses, high MSI (MSI-H), i.e., MSI at 30% or more of the loci examined, was associated with improved survival (P =.02) and time to recurrence (P =.01). The group of patients whose tumors exhibited allelic imbalance at chromosome 8p had decreased survival (P =.02) and time to recurrence (P =.004). No statistically significant associations with survival or time to recurrence were observed for markers on chromosome arms 5q, 15q, 17p, or 18q. In multivariate analyses, MSI-H was an independent predictor of improved survival (hazard ratio [HR] = 0.51; 95% confidence interval [CI] = 0.31-0.82; P =.006) and time to recurrence (HR = 0.42; 95% CI = 0.24-0.74; P =.003), and 8p allelic imbalance was an independent predictor of decreased survival (HR = 1.89; 95% CI = 1.25-2.83; P =. 002) and time to recurrence (HR = 2.07; 95% CI = 1.32-3.25; P =.002).
Conclusions: Patients whose tumors exhibited MSI-H had a favorable prognosis, whereas those with 8p allelic imbalance had a poor prognosis; both alterations served as independent prognostic factors. To our knowledge, this is the first report of an association between 8p allelic imbalance and survival in patients with colorectal cancer.
Comment in
-
Molecular markers of prognosis in colorectal cancer.J Natl Cancer Inst. 1999 Aug 4;91(15):1267-9. doi: 10.1093/jnci/91.15.1267. J Natl Cancer Inst. 1999. PMID: 10433607 No abstract available.
Similar articles
-
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.Dis Colon Rectum. 2004 Sep;47(9):1467-82. doi: 10.1007/s10350-004-0628-6. Epub 2004 Aug 12. Dis Colon Rectum. 2004. PMID: 15486743
-
Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.Clin Cancer Res. 2002 Jul;8(7):2311-22. Clin Cancer Res. 2002. PMID: 12114436
-
Allelic imbalance and microsatellite instability in resected Duke's D colorectal cancer.Diagn Mol Pathol. 1997 Apr;6(2):78-84. doi: 10.1097/00019606-199704000-00002. Diagn Mol Pathol. 1997. PMID: 9098645
-
Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome.Med Oncol. 2012 Sep;29(3):1796-801. doi: 10.1007/s12032-011-0050-6. Epub 2011 Sep 8. Med Oncol. 2012. PMID: 21901450 Review.
-
Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool.Ann Oncol. 2004;15 Suppl 4:iv283-4. doi: 10.1093/annonc/mdh940. Ann Oncol. 2004. PMID: 15477322 Review. No abstract available.
Cited by
-
Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent?Fam Cancer. 2004;3(2):85-91. doi: 10.1023/B:FAME.0000039915.94550.cc. Fam Cancer. 2004. PMID: 15340258 Review.
-
Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma.World J Gastroenterol. 2010 Dec 21;16(47):6026-34. doi: 10.3748/wjg.v16.i47.6026. World J Gastroenterol. 2010. PMID: 21157981 Free PMC article.
-
High-resolution analysis of DNA copy number alterations in rectal cancer: correlation with metastasis, survival, and mRNA expression.Strahlenther Onkol. 2014 Oct;190(11):1028-36. doi: 10.1007/s00066-014-0659-4. Epub 2014 Apr 26. Strahlenther Onkol. 2014. PMID: 24770938 Clinical Trial.
-
A microRNA molecular modeling extension for prediction of colorectal cancer treatment.BMC Cancer. 2015 Jun 18;15:472. doi: 10.1186/s12885-015-1437-0. BMC Cancer. 2015. PMID: 26084510 Free PMC article.
-
Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy.Gastrointest Cancer Res. 2009 Sep;3(5):191-6. Gastrointest Cancer Res. 2009. PMID: 20084160 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical